Literature DB >> 29983689

Spontaneous healing and scar control following enzymatic debridement of deep second-degree burns.

I Mataro1, G Delli Santi2, P Palombo2, R D'Alessio1, M Vestita3.   

Abstract

Scarring after a burn injury remains the greatest unmet challenge in the treatment of functional and psychosocial sequelae of burns. The hypertrophic scar represents the most common type of cicatrix after burns, and it has a prevalence of up to 70%. We present a case of upper and lower extremity partial-thickness burns in a female patient treated in two different modalities. Superficial seconddegree burns on the upper extremities were treated with conservative dressing with fairly early wound closure but they developed hypertrophic scars. Deeper, lower extremity burns were debrided with a new bromelain-based debriding agent, resulting in scar-free healing. The pathophysiology of hypertrophic scar formation is based on the perturbation of collagen production or degradation or both. The duration and magnitude of the inflammatory phase of wound healing also appears to play a role in hypertrophic scarring. Bromelain has demonstrated an anti-angiogenic effect in various cancer cell lines and it has been shown to regulate a variety of pro-angiogenic growth factors. This case raises the classical question of the relationship between time to healing and formation of hypertrophic scars after burn injury, pointing to other potential factors that may play an important role in burn healing.

Entities:  

Keywords:  bromelain; deep second-degree burns; enzymatic debridement; hypertrophic scar; spontaneous healing

Year:  2017        PMID: 29983689      PMCID: PMC6033487     

Source DB:  PubMed          Journal:  Ann Burns Fire Disasters        ISSN: 1592-9558


  8 in total

1.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

Review 2.  Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.

Authors:  E E Tredget; B Nedelec; P G Scott; A Ghahary
Journal:  Surg Clin North Am       Date:  1997-06       Impact factor: 2.741

Review 3.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

Review 4.  Bromelain: biochemistry, pharmacology and medical use.

Authors:  H R Maurer
Journal:  Cell Mol Life Sci       Date:  2001-08       Impact factor: 9.261

5.  Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients.

Authors:  K Eckert; E Grabowska; R Stange; U Schneider; K Eschmann; H R Maurer
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

6.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

Review 7.  Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives.

Authors:  Katya Chobotova; Ann B Vernallis; Fadzilah Adibah Abdul Majid
Journal:  Cancer Lett       Date:  2009-08-22       Impact factor: 8.679

Review 8.  Biology and principles of scar management and burn reconstruction.

Authors:  Edward E Tredget; Benjamin Levi; Matthias B Donelan
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

  8 in total
  2 in total

1.  Regulation of glycolysis and the Warburg effect in wound healing.

Authors:  Roohi Vinaik; Dalia Barayan; Christopher Auger; Abdikarim Abdullahi; Marc G Jeschke
Journal:  JCI Insight       Date:  2020-09-03

2.  A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.

Authors:  Tomasz Korzeniowski; Jerzy Strużyna; Anna M Chrapusta; Andrzej Krajewski; Marek Kucharzewski; Krzysztof Piorun; Jakub Nowakowski; Agnieszka Surowiecka; Magdalena Kozicka; Kamil Torres
Journal:  Med Sci Monit       Date:  2022-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.